What is NOWDiagnostics?
Based in Springdale, Arkansas, NOWDiagnostics, Inc. is redefining the diagnostic testing paradigm. By leveraging its ADEXUSDx product line, the company enables rapid, on-site detection of various conditions and diseases, effectively eliminating the logistical delays associated with traditional off-site laboratory processing. This innovation addresses a critical bottleneck in healthcare delivery, offering providers and patients immediate actionable data. The company's market position is characterized by its focus on high-efficiency, user-centric diagnostic solutions that integrate seamlessly into existing clinical workflows.
How much funding has NOWDiagnostics raised?
NOWDiagnostics has raised a total of $33.4M across 2 funding rounds:
Debt
$10.9M
Series B
$22.5M
Debt (2016): $10.9M, investors not publicly disclosed
Series B (2024): $22.5M led by DigitalDx Ventures, Kompass Kapital Management, and Labcorp venture fund
Key Investors in NOWDiagnostics
DigitalDx Ventures
A venture capital firm specializing in the intersection of artificial intelligence and healthcare, focusing on high-impact, transformative medical technologies.
Kompass Kapital Management
A private equity group that employs conservative underwriting standards to manage a diversified portfolio of active and passive investments across multiple sectors.
Labcorp venture fund
The corporate venture arm of a global life sciences leader, focusing on strategic investments that enhance diagnostic capabilities and laboratory service efficiency.
What's next for NOWDiagnostics?
With the successful closure of its latest financing, NOWDiagnostics is well-positioned to scale its manufacturing capabilities and expand its commercial footprint. The strategic backing from specialized healthcare and private equity investors suggests a focus on accelerating the adoption of its diagnostic platform across diverse clinical settings. Future growth will likely center on broadening the menu of testable conditions and deepening market penetration, as the company seeks to solidify its role as a critical infrastructure provider in the evolving landscape of decentralized healthcare diagnostics.
See full NOWDiagnostics company page
